May 15, 1996 |
ICN Pharmaceuticals Inc. is participating in a joint venture to convert a former Soviet biological warfare production plant in Kazakhstan into a drug-manufacturing factory. ICN said it is teaming up with Allen & Associates International Ltd., a Washington-based business development company, to renovate the plant. ICN expects the facility will be operating by September and will initially employ 250 people. The Kazakhstan project will be funded by a $2.